On the back of phase II trials, its already being hailed as a game-changer
But 10% of employers currently covering GLP-1 drugs for weight loss said they planned to drop the drugs in 2027, according to the Business Group on Health, a policy research group for large employers
Pricing: $199/month for compounded injectable or sublingual semaglutide, $249/month for semaglutide tablets, $299/month for tirzepatide (injectable or tablet)
They are known for their ability to hold water and thus are a great ingredient for dry skin
The FDA placed it in 503A Category 2 ("may present significant safety risks") in 2023, effectively barring compounding pharmacies from using it, then removed it from that category in April 2026 after nominators withdrew their submission, without adding it to the approved Category 1 compounding list
Mechanistically, cholesterol induced a hepatic metabolic reprogramming characterized by enhanced oxidative phosphorylation and antioxidant defenses, coupled with suppression of endoplasmic reticulum (ER) proteostasis